New combo pill tested in healthy volunteers – no cure, just data
NCT ID NCT07102719
First seen Feb 05, 2026 · Last updated Jun 04, 2026 · Updated 18 times
Summary
This study tested a new drug called HD-P023 in 40 healthy adults to see how it compares to taking two diabetes medicines (teneligliptin and empagliflozin) together. The goal was to measure how the body absorbs and processes the drugs, not to treat any disease. Participants were healthy volunteers, and the study is already completed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H Plus Yangji Hospital
Seoul, 08779, South Korea
Conditions
Explore the condition pages connected to this study.